Laporan Laba Rugi (TTM)
Laporan Laba Rugi Aristo Bio-Tech and Lifescience Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2021 03-31 |
2022 03-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,672 | 1,658 | 2,179 | 2,197 | 2,216 | 2,334 | 2,451 | 2,858 | 3,265 | 3,223 | 3,181 |
| Change (%) | -0.87 | 31.43 | 0.87 | 0.86 | 5.29 | 5.05 | 16.59 | 14.23 | -1.28 | -1.30 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 1,502 | 1,472 | 1,960 | 1,985 | 2,010 | 2,136 | 2,265 | 2,638 | 3,015 | 2,989 | 2,958 |
| Change (%) | -1.97 | 33.15 | 1.28 | 1.26 | 6.27 | 6.02 | 16.45 | 14.30 | -0.86 | -1.02 | |
| % of Revenue | 89.79 | 88.80 | 89.97 | 90.34 | 90.70 | 91.54 | 92.39 | 92.29 | 92.35 | 92.75 | 93.01 |
| Gross Operating Profit | 171 | 186 | 219 | 212 | 206 | 197 | 186 | 220 | 250 | 234 | 222 |
| Change (%) | 8.77 | 17.74 | -2.84 | -2.92 | -4.26 | -5.51 | 18.18 | 13.29 | -6.38 | -4.84 | |
| % of Revenue | 10.21 | 11.20 | 10.03 | 9.66 | 9.30 | 8.46 | 7.61 | 7.71 | 7.65 | 7.25 | 6.99 |
| SG&A | 36 | 54 | 58 | 60 | 63 | 49 | 37 | 29 | 21 | 31 | 41 |
| Change (%) | 48.58 | 8.32 | 3.56 | 3.43 | -20.94 | -24.66 | -21.91 | -28.06 | 48.85 | 32.82 | |
| % of Revenue | 2.17 | 3.25 | 2.68 | 2.75 | 2.82 | 2.12 | 1.52 | 1.02 | 0.64 | 0.97 | 1.30 |
| R&D | |||||||||||
| Change (%) | |||||||||||
| % of Revenue | |||||||||||
| OpEx | 1,636 | 1,616 | 2,106 | 2,124 | 2,143 | 2,262 | 2,382 | 2,776 | 3,171 | 3,141 | 3,112 |
| Change (%) | -1.22 | 30.30 | 0.87 | 0.86 | 5.58 | 5.28 | 16.57 | 14.21 | -0.92 | -0.93 | |
| % of Revenue | 97.85 | 97.51 | 96.67 | 96.67 | 96.67 | 96.93 | 97.15 | 97.13 | 97.12 | 97.48 | 97.84 |
| Operating Income | 36 | 41 | 73 | 73 | 74 | 72 | 70 | 82 | 94 | 81 | 69 |
| Change (%) | 15.01 | 75.56 | 0.85 | 0.85 | -2.97 | -2.36 | 17.12 | 14.62 | -13.35 | -15.41 | |
| % of Revenue | 2.15 | 2.49 | 3.33 | 3.33 | 3.33 | 3.07 | 2.85 | 2.87 | 2.88 | 2.52 | 2.16 |
| Interest Expense | -22 | -19 | -22 | -23 | -25 | -18 | -17 | -17 | -17 | -17 | -18 |
| Change (%) | -14.80 | 17.25 | 5.56 | 5.27 | -26.48 | -7.50 | 0.08 | 0.08 | 4.16 | 3.99 | |
| % of Revenue | -1.32 | -1.14 | -1.01 | -1.06 | -1.11 | -0.77 | -0.68 | -0.58 | -0.51 | -0.54 | -0.57 |
| Net Income | 11 | 14 | 36 | 36 | 36 | 37 | 39 | 49 | 59 | 50 | 41 |
| Change (%) | 33.29 | 148.44 | 0.10 | 0.10 | 3.92 | 5.02 | 25.42 | 20.27 | -15.43 | -18.24 | |
| % of Revenue | 0.64 | 0.86 | 1.64 | 1.62 | 1.61 | 1.59 | 1.59 | 1.71 | 1.80 | 1.54 | 1.28 |
Source: Capital IQ
